Introduction
Mulleins (Verbascum spp.) have been used for medicinal purposes since ancient times mainly for respiratory problems due to their anti-inflammatory and antimicrobial properties. Verbascum extracts are currently prescribed as tea products [1] as a source of several compounds possessing a broad range of biological activities. Such properties include antiseptic, sedative, diuretic, antimicrobial, immunomodulatory and antiviral related activities [2] [3] [4] [5] [6] [7] . Dried leaves, flowers, alcoholic and oil extracts are widely available in the health stores in USA [8] .
Arthritis is a joint related disorder resulting from misdirected inflammation which is associated with pain and loss of joint function. In affected joints, a number of cytokines such as interleukin-1 (IL-1), IL-6 and tumor necrosis factor alpha (TNF-α) are produced [9] . Inflammation of the super-thin synovium is accompanied by cartilage swelling that protects the ends of the bones. Many drugs for rheumatoid arthritis deal with inflammation or specific factors involved in inflammation. Examples include non-steroidal anti-inflammatory drugs, steroids, disease-modifying antirheumatic drugs and biologics. A number of treated patients remain refractory or become unresponsive to treatments irrespective of the therapy applied. Recent studies on the use of medicinal plants in treating and preventing ailments has renewed interest in folk medical practices [10] .
As a part of our on-going project to identify medicinal plant substances with anti-inflammatory potentials, we have investigated their in vitro anti-inflammatory properties of the Devil's claw (Harpagophytum procumbens) and their active basis that include verbascoside and harpagoside. Both substances expressed in vitro inhibitory effects on COX-1 and COX-2 expression by activated macrophages [11] . In the present study, we have examined extracts from five Verbascum species and harpagoside. These include V. nigrum (dark mullein), V. phoeniceum (purple mullein), V. phlomoides (orange mullein; two varieties), V. densiflorum (dense flowered mullein) and genetically transformed (via Agrobacterium rhizogenes-mediated transformation) hairy roots of V. xanthophoeniceum (an endemic plant species from the Balkan region which also exists in Northwestern and Southern parts of Turkey). We investigated COX-1 and COX-2 expression by peritoneal macrophages as a screening test for anti-inflammatory response and further the effects of three extracts and harpagoside were tested following administration in mouse models of carrageenan-induced paw oedema (acute inflammation). Harpagoside was tested in zymosan-induced arthritis model (chronic inflammation) and subjected to molecular docking studies.
Experimental Procedures

Chemicals and standards
Harpagoside was obtained from Extrasynthese (Genay, France), while verbascoside (purity >94%) was generously provided by Dr. I. Koleva (University of Food Technology, Plovdiv, Bulgaria). For in vivo injection, both substances were dissolved in DMSO and further diluted in PBS (final DMSO concentration was <0.05%).
Plant material
The Verbascum nigrum L., V. densiflorum Bertol., V. phoeniceum L., V. phlomoides L. (varieties 7 and 33) seeds were provided by courtesy of IPK, Gatersleben (Gatersleben, Germany). All Verbascum seeds were germinated in decontaminated soil and grown under green house conditions at 25°C with an illumination periods of 16 h light and 8 h dark. After four months of growth Verbascum plants were used for analyses. The leaves were harvested at regular intervals on the same day, freeze-dried and stored at -80°C prior to use. The V. xanthophoeniceum hairy roots were obtained as reported before [12] .
Sample preparation and high performance liquid chromatography with diode array detection (HPLC-DAD)
Extraction of Verbascum plant leaves and hairy roots was performed with methanol (solid : liquid ratio 1:50). In brief, 0.9 g of freeze-dried sample was transferred to a 50 ml falcon tube and immersed in 45 ml methanol. Crude metanolic extracts from Verbascum leaves and hairy roots were directly injected into an HPLC-DAD system to quantify verbascoside and harpagoside content. The HPLC-DAD system and the conditions used have been described elsewhere [13] .
Animals
Male ICR (CD-2) mice (8 weeks old) weighing 20-22 g were used. The animals were provided with food and water ad libitum and kept under standard conditions (22±4ºC; 6/18 h light/dark cycle). All experiments were conducted in accordance with the 'Bulgarian National Guidelines for the Care and Use of Laboratory Animals' (Decree No. 14/19.07.2000) and approved by local ethics committee.
Carrageenan-induced paw oedema
Oedema was induced by injecting 50 µl/paw of 1% carrageenan in saline into the right hind paw. The left hind paw was injected with saline and served as a control. Swelling of both paws was measured after 3 h by a caliper. Test extracts (50 mg/kg), verbascoside (20 mg/kg) and harpagoside (10, 20 and 50 mg/kg) were administered intraperitoneally (i.p.) in a volume of 0.2 ml, 30 min prior to carrageenan. As a reference, dexamethasone was used at a dose of 10 mg/kg. Control animals were injected i.p. with 0.2 ml saline.
Zymosan-induced arthritis (ZIA)
Mice were injected intraarticularly (i.a.) with 180 µg zymosan A from Saccharomyces cerevisiae (Z4250, Sigma-Aldrich, Munich, Germany; 10 µl/joint). Ankle swelling and redness of each animal was measured daily for 30 days starting from day 1 post injection.
Clinical score was defined as: 0 -normal ankle; 1 -slight swelling; 3 -moderate swelling and redness; 4 -severe swelling and redness. Harpagoside was administered i.p. in a volume of 0.2 ml at a dose of 20 mg/kg from day 1 to day 10 of ZIA.
Intracellular flow cytometry
Resident peritoneal macrophages were harvested by rinsing the peritoneal cavity of mice with 2 ml of RPMI-1640 medium (Biowhittaker™, Lonza, Verviers, Belgium). The cells were washed twice, resuspended at 2x10
6 cells/ml in RPMI-1640 medium supplemented with 5% fetal calf serum (FCS, Sigma-Aldrich, Munich, Germany). After incubation in 5% CO 2 for 1 h at 37°C, the non-adherent cells were aspirated and the adherent cells were collected and resuspended at 1x10
6 cells/ml in 2% FCS/PBS solution. The cells were stimulated with 5 ng/ml phorbol 12-myristate 13-acetate (PMA, Sigma-Aldrich) and 500 ng/ml ionomycine (SigmaAldrich) in the presence or absence of 500 mg/ml of extracts for 2 h at 37ºC. After washing, macrophages were incubated for 30 min at 4ºC with antibodies against COX-1 (1:100 diluted, PeproTech EC, London, UK) and COX-2 (1:250 diluted, BD Biosciences) or with appropriately diluted isotype controls (SigmaAldrich). After washing in 2% FCS/PBS solution, the cells were stained with secondary FITC-labelled antibodies (1:500 diluted, Sigma-Aldrich) for 15 min at 4ºC. After 4 times washings with PBS, the samples were analysed by a flow cytometer (BD™LSR II) using FCS Express™ Diva Software (both from Beckton and Dickinson, NJ, USA).
Cytokine assay
Blood was collected by retroorbital puncture and as no significant difference between cytokine patterns measured in plasma vs serum samples, cytokine analysis was performed on serum. After clotting for 1 hour at room temperature, samples were centrifuged for 10 min at 3000xg at room temperature and clearly hemolyzed samples were discarded. Sera were collected and frozen at -80°C until further analysis. IL-6 concentration was assessed by a commercial ELISA kit with a detection limit of <62 pg/ml (PeproTech EC, London, UK).
Histological analyses
Dissected ankle joints were fixed in 10% paraformaldehyde/PBS, decalcified in 5% nitric acid for 1 week, dehydrated and embedded in paraffin. Sagital sections (6 mm thickness) were stained with H&E or stained with Weigert's iron hematoxylin followed by 0.001% fast green and 0.1% safranin O staining or with toluidine blue. The sections were examined in a blinded manner. Synovium from knee joint was evaluated on a scale from 0 to 4 (with 0 = normal and 4 = major changes) for hyperplasia, perivascular and tissue cell infiltration. Cartilage degradation was graded from 0 to 3, where 0 = fully stained cartilage, 1 = loss of proteoglycan staining in the superficial layer, 2 = complete loss of proteoglycan staining, and 3 = complete loss of cartilage. Bone erosion was scored as 0 = normal, 1 = mild loss of cortical bone at few sites, 2 = moderate loss of cortical and trabecular bone, and 3 = marked loss of bone at many sites.
Immunohistochemistry
Sections were immersed in 3% H 2 O 2 /60% methanol (10 min) and permeabilized with 0.1% Triton X-100/PBS (20 min). The slides were blocked with 5% BSA/PBS for 40 min. After washing, the sections were incubated for 1 h with antibodies against COX-1 (H-62, 1:500 diluted) or COX-2 (H-62, 1:500 diluted) (SantaCruz Biotechnology). Isotype antibodies (Santa-Cruz Biotechnology) of rabbit origin were used as controls. The sections were incubated with peroxidase-labeled anti-rabbit antibody (1:2000 diluted, Sigma-Aldrich) for 30 min and stained with 3,3'-diaminobenzidinetetrahydrochloride substrate solution (DAB; SigmaAldrich). The sections were counterstained for 30 s with Gill's hematoxylin.
Docking calculations using jolegro virtual docker (MVD)
The MVD MolDock is based on a new heuristic search algorithm that combines differential evolution with a cavity prediction algorithm. One scoring function of MolDock (MolDock Score or MVDScore) is an extension of the piecewise linear potential (PLP) originally proposed by Gehlhaar et al. [14] and later extended by Lee et al. [15] that includes new hydrogen bonding and electrostatic terms. The harpagoside and cyclooxygenases (COX-1, PDB id: 3kk6 and COX-2, PDB id: 6cox) were uploaded with water molecules. Two cavities were detected and the cavities around the inhibitors (volume of approximately 91.65 and 82.94 Å 3 for COX-1 and COX-2, respectively) were used for docking. Calculations were performed with 2 quad core processors Windows™ 7 based computer with 8 GB of RAM and each docking process took about an hour.
Statistics
Statistical significance was evaluated by Mann Whitney or unpaired Student t test. Values < 0.05 were regarded as statistically significant.
Results
Sample analyses
The HPLC-DAD analyses revealed that the phenylethanoid glycoside verbascoside (also known as acteoside) content significantly varied between Verbascum species and their hairy roots (between 0.21 and 3.26%; Table 1 ). The iridoid glycoside harpagoside was detected solely in V. nigrum leaves (~0.68%; Table 1 ).
Effect of Verbascum extracts on COX-1 and COX-2 expression by peritoneal macrophages
In the case of COX-1 we found that all of the tested mulleins extracts strongly inhibited its expression by macrophages stimulated with PMA/ionomycine ( Figure 1) . The most significant inhibition of COX-1 expression (~60% inhibition) was observed for the crude extracts of V. phoeniceum (V32) and V. phlomoides (V7). In regard to COX-2 expression, only V. xanthophoeniceum hairy roots (VX hairy root) and V. phoeniceum (V32) demonstrated suppressive activity of about 45%.
Effect of Verbascum extracts on carrageenan-induced oedema
Data in Figure 2A showed that the crude metanolic extract of V. phoeniceum (V32) and harpagoside (at a dose of 50 and 20 mg/kg) significantly inhibited paw swelling. This effect was relevant to dexamethasone used as a synthetic anti-inflammatory drug (positive control). Verbascoside and V. nigrum extract (V4) did not display significant activity. The inflammation Table 1 . Verbascoside and harpagoside content in Verbascum species and genetically transformed root cultures (determined by HPLC-DAD).
* not detected
was attended with increased plasma IL-6 level. In crude extracts of V. phoeniceum (V32) and V. nigrum, dexamethasone and harpagoside at a concentration of 20 mg/kg suppressed this elevation while verbascoside exhibited weak activity ( Figure 2B ). This emphasized the useful potential of V. phoeniceum crude extracts for treatment of inflammatory disorders and also their eventual inclusion in European Pharmacopoeia.
Harpagoside expressed anti-inflammatory action in zymosan-induced arthritis
The administration of harpagoside during the first 10 days of ZIA resulted in significantly decreased clinical signs of inflammation in acute phase and lead to permanent swelling ( Figure 3A) . The severity of ZIA was evaluated by scoring the histological changes in the joints based on cell infiltration, cartilage loss and erosion. The development of ZIA was associated with intensive cell infiltration in synovium and cartilage, leading to cartilage loss and erosion ( Figure 3B ) and all these events were attenuated by harpagoside. H&E staining of ZIA joints demonstrated the decrease of cell infiltration in harpagoside treated animals. Reduced density of toluidine blue staining in ZIA mice witnessed loss of glycosaminoglycans (GAGs) in the cartilage and significant proteoglycan (PG) depletion in arthritic mice ( Figure 3C ). Cyclooxygenases play pro-inflammatory roles in a variety of diseases including arthritis. We observed that COX-1 and COX-2 expression in joints during ZIA was elevated in the initial acute phase (day 3) while harpagoside treated ZIA mice showed decreased expression ( Figure 4 ). This effect was considered transient because at day 30, no significant difference was apparent for arthritic and non-arthritic groups (data not shown).
Docking of harpagoside with COX-1 and COX-2
Molecular docking simulations of harpagoside was performed at the active site of the enzymes COX-1 and COX-2. Figure 5 showed that the compound was docked into the active site of cyclooxygenases. Docking simulations with MVD revealed different scoring functions and energy features.
Discussion
The present study demonstrated the potential of Verbascum species to induce beneficial effects in acute and chronic inflammatory animal models. The results highlight the involvement of COX-1, COX-2 and macrophage-mediated mechanisms at the cellular level. Activated macrophages are the major source of IL-6, TNF-a, IL-12 and other pro-inflammatory mediators, like prostaglandin E 2 and nitric oxide (NO) which are catalyzed by cyclooxygenase-2 (COX-2).
The overproduction of these mediators cause acute phase tissue injury and perpetuates the chronic phase [16] . Therefore, their inhibition may prevent or suppress a variety of inflammatory diseases. COX-1 and COX-2 appear to be among the desirable targets for suppression of many inflammatory disorders. COX expression is effectively inhibited by dexamethasone or anti-inflammatory cytokines such as IL-4, IL-11, IL-13 [17] . A selective COX-2 inhibitor regime is suggested as an important step in the therapeutic treatment of inflammatory diseases. In support of this potential therapy, extracts from V. phoeniceum were shown to inhibit the expression of both COXs, while the V. phlomoides extract diminished only COX-1 expression and V. xanthophoeniceum hairy roots showed selective inhibition against COX-2 expression. Different in vivo systems have been established to evaluate COX inhibitors. The carrageenan-induced paw edema is a model of acute inflammatory processes often used for testing of COX inhibitors [18] [19] . We searched for a correlation between extract composition (e.g. verbascoside and harpagoside content) and their antiinflammatory activity. Extracts from V. nigrum containing both constituents expressed non-significant reduction of paw swelling in carrageenan oedema although it decreased the concentration of proinflammatory cytokine IL-6 in circulation. In contrast, extracts from V. phoeniceum, containing relatively low amounts of verbascoside (compared to other mulleins) none of harpagosids tested possessed inhibitory properties against acute inflammation attended with diminished IL-6 serum level and suppressed in vitro COX-1 and COX-2 expression by macrophages ( Figure 6 ). Previously, we have shown that verbascoside clearly inhibits COX-1 and COX-2 expression by macrophages [11] . The current data is in agreement with the notion that the overall effect of the total extract strongly depends on the ratio between the constituents and eventually on their synergistic and antagonistic mode of action. Combining the data from the present study with NMR-metabolomics data [13] may provide a clearer idea of the active principles (and their interactions) in V. phoeniceum plants.
A number of investigations have reported the antiinflammatory properties of harpagoside. This compound inhibits paw oedema [20] and also the harpagoside-containing fraction from Devil's claw is mainly responsible for the suppression of COX-2 expression [21] . In the present study, we used zymosaninduced arthritis in mice to evaluate the effect of harpagoside on chronic inflammation. It was administered at the onset of inflammation disease development during the first 10 days and resulted in significant inhibition of clinical symptoms during the onset of arthritis which was maintained after its withdrawal. The decrease of COX-1 and COX-2 expression in cartilage and bone proved its suppressive action on the initiation of inflammation (day 3 after zymosan injection). Histopathological examinations proved that this molecule limited chronic synovitis and changes in cartilage and bone at the late stage of arthritis. Harpagoside was beneficial in regard to cell infiltration and PG loss as well as bone erosion.
The molecular docking studies revealed that O7 atom of the harpagoside hydrogen bonds with a water molecule (#621) at a distance of 2.54 Å with Tyr385 (3.31 Å) and with Ser530 (3.1 Å). O8 atom also showed hydrogen bonding interactions with Ser530 located at a distance of 3.22 Å and with the O5 atom of Met522 (2.48 Å). The overall structure of harpagosiderevealed steric interactions with the residues of COX-1 -Ala527, Ser353, Met522, Ser530, Leu352, Tyr385, Phe518, Gln192, Ile523, Arg120, Val349, Leu359 and Leu531, of the active site of COX-1. Harpagoside also showed steric interactions with the residues of COX-2 -Leu352, Phe518, Leu384, Ala527, Ser530, Tyr385, Ala516, Val523, Arg523, Arg513, Tyr355, SEr353, Leu359, and Arg120. After analyzing the docking and reranking scores from these docking simulations, we conclude that harpagoside compounds may be more specific as inhibitory binders towards COX-1 than COX-2. 
Conclusions
In conclusion, Verbascum species could serve as a potent source of anti-inflammatory molecules and is worthy of further examination in models of chronic inflammation. Harpagoside is a very active molecule, which significantly diminishes symptoms of acute and chronic inflammation in mice models. Therefore, further detailed study on its anti-arthritic mechanism of action is necessary.
